Abstract:Editor'China is facing a blood shortage.1Jin YH Cui J Solution for the problem of blood short supply from the perspective of surgical appropriate transfusion.Chin J Blood Transfusion. 2011; 24 ([Chinese]): 451-453Google Scholar Approximately 60% of blood products are being transfused during clinical surgery.2Gong BL Zhang W Meng QL et al.A survey of blood supply in 357 provincial and municipal blood banks.Chin J Blood Transfusion. 2012; 25 ([Chinese]): 1248-1250Google Scholar We aimed to assess the appropriateness of perioperative red blood cells (RBCs) transfusion in public tertiary general hospitals in China. This study was designed as a retrospective (January 2006–December 2009) multicentre survey involving three typical sample hospitals [The Peking Union Medical College Hospital (PUMC Hospital), the Second Affiliated Hospital of Zhejiang University School of Medicine (SAZU Hospital), and the Northern Jiangsu People's Hospital (NJP Hospital)]. Using a year-stratified random sampling with a sampling proportion of 20% for every stratum, 6384 patients who had a history of RBCs transfusion were selected from three hospitals. Of them, 1274 patients, who had complete records of objective indication, were included in the appropriateness evaluation. A structural survey form was used to extract data from the medical records, which included the patients' general information, surgical information, objective transfusion indication, and blood infusion information. The appropriateness evaluation consisted of two steps. First, a reasonableness evaluation was done by a composite criterion that was mainly based on Chinese blood transfusion guidance.3National Health and Family Planning Commission of China Technological Specification for Clinical Use of Blood.Available from http://www.moh.gov.cn/mohyzs/s3589/200804/18676.shtmlGoogle Scholar, 4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google Scholar, 6British Committee for Standards in Haematology (BCSH) Guideline on the administration of blood components.Available from http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdfGoogle Scholar Then, over-transfusion7NHS Blood and Transplant Comparative audit of red cell use in the hospitals in the South West and West Midlands regions.Available from http://hospital.blood.co.uk/library/pdf/Audit_of_Red_cell_Use_in%202_regions_St_Elsewhere's_Hospital.pdfGoogle Scholar was further assessed among patients who were identified as reasonable transfusion based on the first step. During the study periods, the whole blood transfusion was almost replaced by blood component transfusion after the year 2007. The proportion of blood component transfusion increased from 92.3% in 2006 to 99.6% in 2009. Overall, the unreasonable RBCs transfusion rate significantly decreased from 41.5% [95% confidence interval (CI): 35.2–47.9] to 30.2% (25.9–34.7) during the study periods. The downtrends were consistent in all subgroups (38.7–28.8%, 45.2–23.5%, and 41.9–38.9% at the PUMC, the SAZU, and the NJP Hospital, respectively, all P<0.05). Table 1 shows the distribution characteristics of patients who have undergone unreasonable RBCs transfusions. The unreasonable rate in thoracic surgery patients was highest [56.8% (46.3–67.0)], followed by heart/blood vessel surgery patients [47.7% (39.7–55.9)]. Patients without anaemia on admission had more than twice the unreasonable rate as did anaemia patients, especially at the SAZU (64.7% vs 17.9%, P<0.0001) and the NJP Hospital (68.7% vs 24.2%, P<0.0001). In fact, when surgical acute blood loss was replaced by crystalloid or colloid fluids to maintain normovolaemia, in most stable hospitalized patients with adequate preoperative haemoglobin, the loss could often be well tolerated due to normal compensatory responses that are invoked before a blood transfusion becomes necessary.4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google ScholarTable 1Distribution characteristics of patients who were identified as unreasonable RBCs transfusions. *95% CIPUMC HospitalSAZU HospitalNJP HospitalTotalUnreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Gender Male108/25542.4 (36.2–48.7)59/14540.7 (32.6–49.2)76/16047.5 (39.6–55.5)243/56043.4 (39.2–47.6) Female100/34628.9 (24.2–34.0)39/13129.8 (22.1–38.4)65/14744.2 (36.0–52.6)204/62432.7 (29.0–36.5)Anaemia on admission Non-anaemia146/30248.3 (42.6–54.1)66/10264.7 (54.6–73.9)103/15068.7 (60.6–76.0)315/55456.9 (52.6–61.0) Anaemia63/28921.8 (17.2–27.0)31/17317.9 (12.5–24.5)37/15324.2 (17.6–31.8)131/61521.3 (18.1–24.8)Operative sites Head/neck17/3351.5 (33.5–69.2)7/3023.3 (9.9–43.4)14/2458.3 (36.6–77.9)38/8743.7 (33.1–54.7) Thoracic14/3540.0 (23.8–57.9)5/1145.5 (16.8–76.6)35/4971.4 (56.7–83.4)54/9556.8 (46.3–67.0) Abdomen91/28132.4 (27.0–38.2)32/9035.6 (25.7–46.4)49/13835.5 (27.6–44.1)172/50933.8 (29.7–38.1) Limbs/spinal column52/15134.4 (26.9–42.6)41/12433.1 (24.9–42.1)17/6426.6 (16.3–39.1)110/33932.4 (27.5–37.7) Heart/blood vessel35/10234.3 (25.2–44.4)13/2161.9 (38.4–81.9)26/3281.3 (63.6–92.8)74/15547.7 (39.7–55.9) Open table in a new tab Overall, the over-transfusion rate was 10.1%. Nearly, half of the over-transfusion episodes occurred in abdominal operations (consistently in three hospitals). Abdominal surgery accounted for the highest proportion of all surgeries (37.6%) and consumed the largest number of RBCs transfusions (38.4%). Improved transfusion practices during abdomen surgery might conserve scarce blood resources largely because of its substantial operation quantity. After controlling for the hospital, the over-transfusion rate in patients without anaemia on admission was significantly higher than that in anaemic patients (16.9% vs 6.8%, P<0.0001). This study suggests that perioperative blood transfusion is gradually being standardized in China. However, rational blood usage still requires improvements. The low proportion of patients who have complete indication records indicated that an objective indication-guided blood transfusion needs to be further strengthened. Patients who had undergone thoracic, abdominal surgery, or without anaemia on admission were considered as potential populations for blood conservation. Our results are unlikely to be conclusive because of the typical sampling design. Nevertheless, these data have sounded alarm bells for perioperative blood conservation in China. None declared. National Health and Family Planning Commission of the People's Republic of China.

A Primary Survey of Blood Transfusion Rationality for Hip Replacement Patients

An investigation of blood transfusion rationality and early hemoglobin level in elderly patients undergoing hip replacement

Blood Conservation Strategies in Cardiac Valve Replacement

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

Application of postoperative autotransfusion in total joint arthroplasty reduces allogeneic blood requirements: a meta-analysis of randomized controlled trials

Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

[Risk Factors of Allogeneic Red Blood Transfusion Following Enhanced Recovery Hip and Knee Arthroplasty].

Influential factors for allogenic blood transfusion after total hip arthroplasty for femoral neck fractures

Perioperative transfusion analysis and blood ordering schedule update for total knee arthroplasty

Trends, complications, and readmission of allogeneic red blood cell transfusion in primary total hip arthroplasty in china: a national retrospective cohort study

Expeience of Autologous Blood Transfusion Methods Using in Unilateral Primary Total Hip Rthroplasties

The Use of Predeposit Autologous Transfusions in Total Hip Replacement

Analysis of a Large Data Set to Identify Predictors of Blood Transfusion in Primary Total Hip and Knee Arthroplasty

Incidence and Risk Factors for Blood Transfusion in Simultaneous Bilateral Total Joint Arthroplasty: A Multicenter Retrospective Study.

Risk factors for postoperative allogenic blood transfusion after unilateral hip surgery in elderly patients

Preoperative Anemia and Blood Transfusion Requirement during Hip Surgery: Synthetic and Real Patient Cohort Data

Preoperative Elevated International Normalized Ratio Cannot Increase Transfusion or Complication in Primary Total Hip Arthroplasty: A Retrospective Study of 552 Cases

Blood Transfusion in the Age of Tranexamic Acid: Who Needs a Type and Screen Before Total Hip Arthroplasty?

Multicentre Evaluation of Perioperative Red Blood Cells Transfusions in China

Restrictive Versus Liberal Strategy for Red Blood-Cell Transfusion: A Systematic Review and Meta-Analysis in Orthopaedic Patients

Incidence and Risk Factors for Blood Transfusion in Simultaneous Bilateral Total Hip Arthroplasty.